dexrazoxane

出典: meddic

デクスラゾキサン

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/02/02 23:07:09」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.
  • Jirkovský E, Lenčová-Popelová O, Hroch M, Adamcová M, Mazurová Y, Vávrová J, Mičuda S, Simůnek T, Geršl V, Stěrba M.SourceDepartment of Pharmacology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, Hradec Králové 500 38, Czech Republic.
  • Toxicology.Toxicology.2013 Sep 15;311(3):191-204. doi: 10.1016/j.tox.2013.06.012. Epub 2013 Jul 4.
  • Despite incomplete understanding to its mechanism of action, dexrazoxane (DEX) is still the only clearly effective cardioprotectant against chronic anthracycline (ANT) cardiotoxicity. However, its clinical use is currently restricted to patients exceeding significant ANT cumulative dose (300mg/m(2))
  • PMID 23831762
  • Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis.
  • Kalam K, Marwick TH.SourceMenzies Research Institute Tasmania, University of Tasmania, Hobart, Australia.
  • European journal of cancer (Oxford, England : 1990).Eur J Cancer.2013 Sep;49(13):2900-9. doi: 10.1016/j.ejca.2013.04.030. Epub 2013 May 22.
  • BACKGROUND: Cardiotoxicity is a well-recognised complication of chemotherapy with anthracycline and/or trastuzumab, and its prevention remains an important challenge in cancer survivorship. Several successful preventative strategies have been identified in animal trials. We sought to assemble the cl
  • PMID 23706982
  • Educational Paper: Decreasing the burden of cardiovascular disease in childhood cancer survivors: An update for the pediatrician.
  • Dillenburg RF, Nathan P, Mertens L.SourceDivision of Cardiology, Department of Pediatrics, McMaster University Children's Hospital, Hamilton, Ontario, Canada.
  • European journal of pediatrics.Eur J Pediatr.2013 Sep;172(9):1149-60. doi: 10.1007/s00431-013-1931-9. Epub 2013 Jan 30.
  • The cardiovascular impact of cancer therapies on the heart is one of the major concerns in the long-term follow-up of childhood cancer survivors (CCSs). Long-term cardiovascular effects include the development of left ventricular dysfunction resulting in congestive heart failure and ischemic heart d
  • PMID 23361962

和文文献

  • 抗がん剤漏出時の対応法 (特集 造血器腫瘍の治療における支持療法の進歩)
  • Intrapleural extravasation of epirubicin, 5-fluouracil, and cyclophosphamide, treated with dexrazoxane
  • UGES Joris W. F.,VOLLAARD Albert M.,WILMS Erik B.,BROUWER Rolf E.
  • International journal of clinical oncology : official journal of the Japan Society of Clinical Oncology 11(6), 467-470, 2006-12-01
  • NAID 10020571872

関連リンク

Dexrazoxane Hydrochloride[デクスラゾキサン ]のFDA承認 (日本語訳) 適応となる癌 塩酸デクスラゾキサンはある種の抗癌剤による重大な副作用の治療に対してFDAによって承認されました。デクスラゾキサンは以下の治療によって使用 ...
Name Language First published Last updated Questions and answers on the review of dexrazoxane-containing medicines, powder for solution for infusion, 500 mg BG = bălgarski 2011-06-24 2012-01-16 ...

関連画像


押しても画像が表示されない場合はサーバが混雑しています。2週間ほどあけて、再度押下してください。


★リンクテーブル★
リンク元デクスラゾキサン」「razoxane

デクスラゾキサン」

  [★]

dexrazoxane
サビーン
ラゾキサン


razoxane」

  [★]

ラゾキサン

dexrazoxane




★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡